Get started
Author

Châu Lê Ngọc

Observed name: Chau Le Ngoc
ORCID: 0000-0002-7702-9392
Observed ORCID: 0000-0002-7702-9392
OpenAlex ID: A5007293292
Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam
2019 · Chau Le Ngoc, Thanh Tran Thi Thanh, et al. · PLoS ONE · 19
PDF
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial
2025 · Graham S Cooke, Le Manh Hung, et al. · The Lancet · 18
PDF
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study
2023 · Barnaby Flower, Le Manh Hung, et al. · eLife · 17
High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study
2021 · Barnaby Flower, Leanne McCabe, et al. · Open Forum Infectious Diseases · 16
PDF
A tightly clustered hepatitis E virus genotype 1a is associated with endemic and outbreak infections in Bangladesh
2021 · Trang Nguyen Hoa, Saif Ullah Munshi, et al. · PLoS ONE · 15
PDF
Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure
2023 · Barnaby Flower, Phuong Nguyen Thi Ngoc, et al. · Clinical Liver Disease · 1
PDF
Unravelling HCV diversity and resistance in Viet Nam: a cross-sectional analysis
2026 · Chau Le Ngoc, Haiting Chai, et al. · The Lancet Regional Health - Western Pacific
Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial
2026 · Hugo C. Turner, Sayara Ahmed, et al. · EClinicalMedicine
Đặc Điểm Của Người Bệnh Viêm Gan Vi Rút C Mạn Tính Trước Điều Trị Bằng Phác Đồ Daas Tại 02 Bệnh Viện Bệnh Nhiệt Đới
2025 · Hiếu Nguyễn Trọng, Hương Vũ Thị Thu, et al. · Tạp chí Y học Việt Nam
PDF
LBP-022 Treatment options to support the elimination of hepatitis C: an open label, factorial randomised controlled trial
2025 · Graham S Cooke, Manh Hung Le, et al. · Journal of Hepatology
Author response: Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study
2022 · Barnaby Flower, Le Manh Hung, et al. · eLife
Works count: 11
Citation count: 86
H-index: 5
I10-index: 5
Year
Topic
Type